Literature DB >> 22804746

The molecular determinants of CD8 co-receptor function.

David K Cole1, Bruno Laugel, Mathew Clement, David A Price, Linda Wooldridge, Andrew K Sewell.   

Abstract

CD8(+) T cells respond to signals mediated through a specific interaction between the T-cell receptor (TCR) and a composite antigen in the form of an epitopic peptide bound between the polymorphic α1 and α2 helices of an MHC class I (MHCI) molecule. The CD8 glycoprotein 'co-receives' antigen by binding to an invariant region of the MHCI molecule and can enhance ligand recognition by up to 1 million-fold. In recent years, a number of structural and biophysical investigations have shed light on the role of the CD8 co-receptor during T-cell antigen recognition. Here, we provide a collated resource for these data, and discuss how the structural and biophysical parameters governing CD8 co-receptor function further our understanding of T-cell cross-reactivity and the productive engagement of low-affinity antigenic ligands.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22804746      PMCID: PMC3461395          DOI: 10.1111/j.1365-2567.2012.03625.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  79 in total

1.  CD8αα and -αβ isotypes are equally recruited to the immunological synapse through their ability to bind to MHC class I.

Authors:  Vasily Rybakin; Jean-Pierre Clamme; Jeanette Ampudia; Pia P Yachi; Nicholas R J Gascoigne
Journal:  EMBO Rep       Date:  2011-12-01       Impact factor: 8.807

Review 2.  The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells.

Authors:  Bruno Laugel; David K Cole; Mathew Clement; Linda Wooldridge; David A Price; Andrew K Sewell
Journal:  J Leukoc Biol       Date:  2011-09-27       Impact factor: 4.962

3.  Plasticity of human CD8αα binding to peptide-HLA-A*2402.

Authors:  Yi Shi; Jianxun Qi; Aikichi Iwamoto; George F Gao
Journal:  Mol Immunol       Date:  2011-06-06       Impact factor: 4.407

4.  Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Authors:  Maria Candela Iglesias; Jorge R Almeida; Solène Fastenackels; David J van Bockel; Masao Hashimoto; Vanessa Venturi; Emma Gostick; Alejandra Urrutia; Linda Wooldridge; Mathew Clement; Stéphanie Gras; Pascal G Wilmann; Brigitte Autran; Arnaud Moris; Jamie Rossjohn; Miles P Davenport; Masafumi Takiguchi; Christian Brander; Daniel C Douek; Anthony D Kelleher; David A Price; Victor Appay
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

5.  αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities.

Authors:  Anastasia N Tikhonova; François Van Laethem; Ken-ichi Hanada; Jinghua Lu; Leonid A Pobezinsky; Changwan Hong; Terry I Guinter; Susanna K Jeurling; Günter Bernhardt; Jung-Hyun Park; James C Yang; Peter D Sun; Alfred Singer
Journal:  Immunity       Date:  2011-12-29       Impact factor: 31.745

Review 6.  Structural and biophysical determinants of αβ T-cell antigen recognition.

Authors:  John S Bridgeman; Andrew K Sewell; John J Miles; David A Price; David K Cole
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

7.  Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination.

Authors:  Ning Jiang; Jun Huang; Lindsay J Edwards; Baoyu Liu; Yan Zhang; Carrie D Beal; Brian D Evavold; Cheng Zhu
Journal:  Immunity       Date:  2011-01-20       Impact factor: 31.745

8.  MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.

Authors:  Linda Wooldridge; Mathew Clement; Anna Lissina; Emily S J Edwards; Kristin Ladell; Julia Ekeruche; Rachel E Hewitt; Bruno Laugel; Emma Gostick; David K Cole; Reno Debets; Cor Berrevoets; John J Miles; Scott R Burrows; David A Price; Andrew K Sewell
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

9.  Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.

Authors:  Mathew Clement; Kristin Ladell; Julia Ekeruche-Makinde; John J Miles; Emily S J Edwards; Garry Dolton; Tamsin Williams; Andrea J A Schauenburg; David K Cole; Sarah N Lauder; Awen M Gallimore; Andrew J Godkin; Scott R Burrows; David A Price; Andrew K Sewell; Linda Wooldridge
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

10.  CD8 controls T cell cross-reactivity.

Authors:  Linda Wooldridge; Bruno Laugel; Julia Ekeruche; Mathew Clement; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

View more
  26 in total

1.  Duality of the murine CD8 compartment.

Authors:  Raphaël Genolet; Julie Leignadier; Magne Østerås; Laurent Farinelli; Brian J Stevenson; Immanuel F Luescher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-04       Impact factor: 11.205

2.  Knockout of CD8 delays reendothelialization and accelerates neointima formation in injured arteries of mouse via TNF-α inhibiting the endothelial cells migration.

Authors:  Jun-Meng Zhang; Ying Wang; Yan-Ju Miao; Yi Zhang; Yi-Na Wu; Li-Xin Jia; Yong-Fen Qi; Jie Du
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

3.  An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.

Authors:  Niels Schaft; Miriam Coccoris; Joost Drexhage; Christiaan Knoop; I Jolanda M de Vries; Gosse J Adema; Reno Debets
Journal:  Front Immunol       Date:  2013-09-04       Impact factor: 7.561

4.  Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.

Authors:  Chihiro Motozono; James A Pearson; Evy De Leenheer; Pierre J Rizkallah; Konrad Beck; Andrew Trimby; Andrew K Sewell; F Susan Wong; David K Cole
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

5.  Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.

Authors:  G Dolton; A Lissina; A Skowera; K Ladell; K Tungatt; E Jones; D Kronenberg-Versteeg; H Akpovwa; J M Pentier; C J Holland; A J Godkin; D K Cole; M A Neller; J J Miles; D A Price; M Peakman; A K Sewell
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.

Authors:  Jennifer D Stone; David M Kranz
Journal:  Front Immunol       Date:  2013-08-21       Impact factor: 7.561

7.  Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.

Authors:  John A H Hoerter; Joanna Brzostek; Maxim N Artyomov; Steven M Abel; Javier Casas; Vasily Rybakin; Jeanette Ampudia; Carina Lotz; Janet M Connolly; Arup K Chakraborty; Keith G Gould; Nicholas R J Gascoigne
Journal:  J Exp Med       Date:  2013-08-12       Impact factor: 14.307

8.  Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.

Authors:  Robson G Dossa; Tanya Cunningham; Daniel Sommermeyer; Indira Medina-Rodriguez; Melinda A Biernacki; Kimberly Foster; Marie Bleakley
Journal:  Blood       Date:  2017-10-19       Impact factor: 25.476

9.  Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells.

Authors:  Abel Torres-Espín; Joaquim Hernández; Xavier Navarro
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

Review 10.  Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy.

Authors:  Barbara Szomolay; Tamsin Williams; Linda Wooldridge; Hugo Antonius van den Berg
Journal:  Front Immunol       Date:  2013-10-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.